CORONAVIRUS/Taiwan, Australia to team up on COVID-19 drug study
Taipei, May 14 (CNA) Taiwanese and Australian university researchers will work together on developing new drugs with potential efficacy against various viruses, including the SARS-CoV-2 virus that causes the COVID-19 disease, Taiwan's Ministry of Science and Technology (MOST) said Thursday.
In video conference call on May 7, researchers from Australia's Monash University and Taiwan's Chang Gung University (CGU) expressed a strong desire to embark on a study and reached an agreement on the areas in which they will cooperate, the ministry said.
Under the agreement, Taiwan will provide strains of the SARS-CoV-2 and other viruses, and Australia will provide the anti-parasitic drug Ivermectin to study its effectiveness against COVID-19, the ministry said, adding the research will be carried out in Taiwan laboratories.
The cooperation will focus on identifying novel therapeutic drug targets against COVID-19 and will be expanded to study their effectiveness against other viruses, including HIV, dengue, Zika, and influenza, the ministry said.
The two universities have decided to sign a cooperation deal and a non-disclosure agreement, after which they will quickly embark on the studies, according to the ministry.
The agreement on the joint research, which may lead to the development of a drug for COVID-19, was initiated by MOST after it learned of studies in Australia that showed the anti-parasitic drug Ivermectin eliminating the SARS-CoV-2 virus in cells within 48 hours in a laboratory setting.
The studies were conducted by Monash University's Biomedicine Discovery Institute and the Peter Doherty Institute for Infection and Immunity in Australia, and the former released its findings on April 3.
Taiwan's representative office in Australia then approached the universities to propose further research in collaboration with CGU, according to Shih Shin-ru (施信如), director of the CGU Research Center for Emerging Viral Infections, who will serve as the project manager in Taiwan.
Established in 2009, CGU's Research Center for Emerging Viral Infections receives subsidies from MOST and plays a leading role in Taiwan's response to diseases like SARS and H1N1 and their effects on the society, economy, transportation, ecology and education.
- CECC seeking info on man diagnosed with COVID-19 after leaving TaiwanThe Central Epidemic Command Center (CECC) on Saturday said it was seeking additional information on a man who was diagnosed with COVID-19 in Malaysia Friday after arriving from ...08/15/2020 05:08 PM
- Taiwan sees new COVID-19 case imported from PhilippinesTaiwan on Saturday recorded one new case of COVID-19, bringing the total number of cases in the country to 482 since the pandemic began, according to the Central Epidemic Command ...08/15/2020 04:51 PM
- Public health experts debate universal COVID-19 testingPublic health experts on Wednesday offered differing views on whether Taiwan should test all incoming arrivals for COVID-19, at a press conference held by National Taiwan ...08/13/2020 11:18 PM
KMT chair vows to win back Kaohsiung mayorship in 202208/15/2020 11:03 PM
POW sufferings remembered in Taiwan on 75th anniversary of end of WWII08/15/2020 09:20 PM
591 divers in Taiwan set Guinness World Record for ocean cleanup08/15/2020 09:01 PM
DPP's Chen Chi-mai wins Kaohsiung by-election by wide margin (update)08/15/2020 08:35 PM
HTC incurs more losses in Q2 but gross margin up08/15/2020 07:06 PM